Bioventures Investors IV Limited Partnership
Bioventures II · adviser of record: Bioventures II Management Corporation · 2014 vintage
Bioventures Investors IV Limited Partnership is a 2014 venture fund managed by Bioventures II, with $30.1mm raised (Form D, amount sold). It reported $27.3mm in gross assets at year-end 2025, 0.91x its size, against a peak of $30.6mm in 2017.
- Latest value held
- $27.3mm year-end 2025
- Peak
- $30.6mm year-end 2017
- Fund size
- $30.1mm Form D, amount sold
- Held vs. size
- 0.91x peak 1.02x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $27.3mm | 0.91x | +0% over 2 yrs |
| 2023 | $27.2mm | 0.90x | +3% |
| 2022 | $26.3mm | 0.87x | +7% |
| 2021 | $24.6mm | 0.82x | -2% |
| 2020 | $25mm | 0.83x | -7% |
| 2019 | $26.8mm | 0.89x | -10% |
| 2018 | $29.8mm | 0.99x | -3% |
| 2017 | $30.6mm | 1.02x | +2% |
| 2016 | $30.2mm | 1.00x | +57% |
| 2015 | $19.2mm | 0.64x | -1% |
| 2014 | $19.3mm | 0.64x | – |
Other funds from Bioventures II
- Bioventures Investors Medtech Growth Capital LP 2020
- Bioventures Investors (Offshore) IV Limited Partnership 2014
- Bioventures Investors Limited Partnership II 2011
- Bioventures Investors III Limited Partnership 2011
- Bioventures Investors (Offshore) III LP 2011
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-3492963963. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.